RBM Achieves Milestone in Companion Diagnostic Project with Roche
May 27, 2011
RBM Achieves Milestone in Companion Diagnostic Project with Roche
Using its DiscoveryMAP protein biomarker discovery platform, the company identified a biomarker pattern useful in monitoring disease progression and predicting and monitoring the efficacy of a compound in Roche's CNS pipeline.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.